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Background: Japanese encephalitis virus (JEV) is the causative agent of Japanese encephalitis which is more
prevalent in South and Southeast Asia. JEV is a neurotropic virus which infiltrates into the brain through vascular
endothelial cells. JEV infects neurons and microglial cells which causes neuronal damage and inflammation.
However, JEV also evades the cellular immune response to survive in host cells. Viruses are known to modulate the
expression of microRNAs, which in turn modulate cellular immune response by targeting expression of antiviral
genes. The aim of this study is to understand the anti-inflammatory role of miR-146a during JEV infection, which
facilitates immune evasion.
Methods: Human brain microglial cells (CHME3) were infected by JEV: JaOArS982 and P20778 strain, and expression
of miR-146a were analyzed. Overexpression and knockdown studies of miR-146a were done to see the effect on
NF-κB pathway and antiviral Jak-STAT pathway. Regulatory role of miR-146a on expression of interferon-stimulated
genes was determined by real-time PCR and luciferase assays.
Results: JEV infection elevated the expression of miR-146a in JaOArS982 strain which caused downregulation of TRAF6,
IRAK1, IRAK2, and STAT1 genes. Exogenous overexpression of miR-146a led to suppression of NF-κB activation and
abrogation of Jak-STAT pathway upon JEV infection which led to downregulation of interferon-stimulated genes (IFIT-1
and IFIT-2) and facilitated viral replication. JEV infection initially upregulated cytokine production and activated STAT1
activity but STAT1 levels reduced at later time point, which led to the downregulation of interferon-stimulated genes.
Conclusion: Upregulation of miR-146a by JEV JaOArS982 strain leads to suppression of NF-κB activity and disruption of
antiviral Jak-STAT signaling which helps the virus to evade the cellular immune response. This effect of JEV infection on
miR-146a expression was found to be strain specific.
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Japanese encephalitis virus (JEV) is a mosquito-borne
neurotropic virus which belongs to the family flaviviri-
dae. JEV is mostly prevalent in South and Southeast
Asia. JEV leads to death of 25% of infected patients
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unless otherwise stated.loss of memory, and cognitive dysfunction [1]. JEV
causes encephalitis and death in patients. A comparative
study between the different parts of the brain depicted
that JEV has more affinity to the midbrain and thalamus
[2]. JEV maintains a zoonotic life cycle where pigs are
major reservoir hosts and mosquitoes act as vectors [3].
JEV infects macrophages and PBMCs [4] and infected
macrophages help the virus to cross blood brain barrier
[5]. However JEV also persists latently in T-lymphocytes
[6] and PBMCs [7]. JEV has been also reported to sup-
press dendritic cell maturation and causes expansion of
Treg cells [8]. Hence, JEV evades the cellular innate
response which facilitates its survival in the host. JEVl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Sequence of RNA oligos used
Name of oligos Sequences
miR-146a mimic UGAGAACUGAAUUCCAUGGGUU
Scramble GGAUGUAUGCUGCUGCUAAUAA
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which leads to neuronal damage due to inflammation
[9]. Microglial cells are resident macrophages in the
brain which harbor JEV. A study on mouse microglial
cells demonstrated persistence of JEV in microglial cells
and suggested that these cells may serve as reservoirs for
virus [10].
MicroRNAs are the small regulatory RNAs which are 19
to 24 nucleotides in length and are reported to regulate the
expression of around 60% of human genes [11]. Micro-
RNAs (miRNAs) lead to regulation of gene expression by
binding to complementary sites present in 3′UTR of target
gene via their seed region [12,13]. Viruses modulate the ex-
pression of cellular microRNAs [14] which may help the
virus to augment its replication [15] or in evasion of cellu-
lar immune response [16]. Recently, the expression of miR-
29b [17] and miR-155 [18] has been reported to be modu-
lated upon JEV infection. Viruses like DENV, CHIKV and
VSV have been reported to overexpress miR-146a which
helps the virus to shut down inflammatory responses of cell
[19,20,21]. miR-146a is a well-known anti-inflammatory
microRNA which targets TNF receptor-associated factor 6
(TRAF6) and IL-1 receptor associated kinase-1 (IRAK1)
and IRAK 2 genes [20]. These genes encode for various
adaptor proteins involved in NF-κB activation. miR-146a
has been also reported to target STAT1 gene which acts as
a transcription factor for expression of interferon-
stimulated genes [22]. miR-146a is induced by NF-κB acti-
vation, where induction of miR-146a targets genes involved
in NF-κB activation and forms a regulatory negative feed-
back loop in monocytes [23]. miR-146a was found to be
overexpressed in Tregs and its deficiency led to disruption
of immunological tolerance in mice [24]. miR-146a overex-
pression leads to suppression of cellular inflammatory re-
sponse and decrease in cytokine secretion [25,26].
In our study, we found that JEV-induced miR-146a up-
regulation led to the downregulation of TRAF6 and IRAK1
and IRAK2 genes and suppression of NF-κB activation
along with decreased expression of pro-inflammatory cyto-
kines. The initial activation of NF-κB by virus resulted in
increased expression of miR-146a, which targeted the
adapter molecules involved in NF-κB activation through a
negative feedback loop. JEV-mediated miR-146a upregula-
tion downregulated the STAT1 expression and abrogated
the Jak-STAT pathway, which led to the decreased expres-
sion of interferon-stimulated genes (ISGs). This observa-
tion suggested the exploitation of cellular miR-146a by JEV
to suppress cellular inflammatory responses in order to
create favorable cellular environment for their survival.
Materials and methods
Cell culture
Human microglial cell line CHME3 was obtained as a
gift from Dr. Anirban Basu (National Brain ResearchCentre, Manesar, Haryana). CHME3 cells were grown in
Complete Dulbecco Modified Eagle Medium (DMEM)
(#12100-046, Gibco, Rockville, MD, USA) with 10%
heat-inactivated fetal bovine serum (16000–044; Gibco
BRL) and 100 U penicillin and 100 μg/ml streptomycin
(#10378016; Gibco-BRL). Porcine stable kidney cells (PS
cells) for JEV Plaque Assay and C6/36 cells for JEV
propagation were also cultured in Complete Dulbecco
Modified Eagle Medium.
JEV propagation and infection
JEV strains (JaOArS982 and P20778 Vellore strain) were
given as a gift by Dr. Anirban Basu, NBRC which was
further propagated in mosquito cell line C6/36 (Aedes
albopictus). The 2 × 105 cells were seeded in 75-cm2
flask and infected with JEV at MOI 0.1 in incomplete
DMEM (without FBS and antibiotic) medium. The in-
complete DMEM media was replaced by complete
DMEM media 3 h post infection, and cells were incubated
for 8 days in humidified 5% CO2 incubator at 28°C. The
supernatant was collected, and the virus was precipitated
using PEG virus precipitation kit (#ab102538; Abcam,
Cambridge, MA, USA). Virus titer was determined by
using plaque assay. For plaque assay, 2 × 105 PS cells were
seeded in six-well plates and different dilutions of virus
(10−3 to 10−9) were used for infection. Three hours post
infection, cells were washed with PBS and agarose overlay
medium (2X incomplete DMEM, 5% FBS, 2% low melting
agarose, and 1% penicillin-streptomycin) was added on
cells and kept at 37°C incubator for 72 h. Later, the cells
were fixed by 10% formaldehyde and the overlay was re-
moved. The cells were stained with crystal violet stain, and
plaques were counted to determine the virus titer. For in-
fection experiments, 5 × 105 CHME3 cells were seeded in
25 cm2 flask and infected by JEV at MOI 5 in incomplete
DMEM. Three hours post infection, the media was re-
placed by complete DMEM and cells were harvested at
24 h post infection.
miR-146a overexpression
CHME3 cells were seeded in six-well dishes, and 100 pmol
of miR-146a seed sequence mimic (Bioserve, Hyderabad,
India) was transfected by using Lipofectamine 2000
(#11668-019; Invitrogen, Carlsbad, CA, USA) according to
manufacturer’s protocol. Scrambled seed sequence of
miR-146a and mock Lipofectamine treatment were used
as control. The sequence of miR-146a oligo and scramble
has been mentioned in Table 1. The overexpression of
Table 2 List of primers used for real-time PCR
Genes Primer sequences
IL-6 Forward: 5′ ACTCACCTCTTCAGAACGAATTG 3′
Reverse: 5′CCATCTTTGGAAGGTTCAGGTTG 3′
TNF-α Forward: 5′ CCTCTCTAATCAGCCCTCTG 3′
Reverse: 5′GAGGACCTGGGAGTAGATGAG 3′
JEV NS3 Forward: 5′ AGAGCGGGGAAAAAGGTCAT 3′
Reverse: 5′ TTTCACGCTCTTTCTACAGT 3′
GAPDH Forward: 5′ ATGGGGGAAGGTGAAGGTCG 3′
Reverse: 5′ GGGGTCATTGATGGCAACAATA 3′
IFIT-1 Forward: 5′ AGAAGCAGGCAATCACAGAAAA 3′
Reverse: 5′ CTGAAACCGACCATAGTGGAAAT 3′
IFIT-2 Forward: 5′ CACATGGGCCGACTCTCAG 3′
Reverse: 5′ CCACACTTTAACCGTGTCCAC 3′
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probe. The cells were harvested after 48 h post transfec-
tion for RNA isolation and Western blotting.
Anti-miR-146a (miR inhibitor) overexpression
CHME3 cells were transfected with 100 pmol of anti-
miR-146a (#AM 10722, Ambion) along with 100 pmol
Cy3-labeled scrambled anti-miR (#AM17011; Ambion)
as negative control by using Lipofectamine transfection
reagent. Cy3-labeled control enables to determine trans-
fection efficiency into cells. Knockdown of miR-146a
was confirmed by real-time PCR using Taqman probe.
Cells were harvested 48 h post transfection.
RNA isolation and real-time PCR
Qiagen miRNeasy kit (#217004; Qiagen, Venlo, Netherlands)
was used for miRNA isolation from harvested cells. Com-
plementary DNA (cDNA) synthesis was done by using
multiscribe TaqMan reverse transcriptase (#4366596; Ap-
plied Biosystems, Waltham, MA, USA) with miR-146a
specific primers. Real-time analysis of miR-146a level was
done by real-time PCR (ABI VII A7 RT-PCR) by using
miR-146a-specific TaqMan probe and universal PCR mas-
ter mix (#4324018; Applied Biosystems). The expression
of miR-146a was normalized by endogenous control
RNU24 expression.
For estimation of IL-6, IFIT-1, and IFIT-2 transcript
levels and viral RNA, total RNA was extracted by using
RNeasy mini kit (Qiagen, Cat No. 74106) according to
manufacturer’s protocol. Quantification of RNA was
done, and cDNA was prepared by using superscript II
(Invitrogen, Cat No. 11904-018) according to manufac-
turer’s protocol. List of primers used in this study is
given in Table 2.
Western blotting
The harvested cell pellet was lysed in RIPA buffer
(150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS) with 1 μM PMSF
and 1X proteCEASE-50 (#427P; G-Biosciences, St. Louis,
MO, USA). The lysate was sonicated, and protein was
quantified by bicinchoninic acid (BCA) assay. Equal
amount of protein was loaded into each well, resolved on
12% SDS-PAGE gel, and transferred on PVDF membrane.
Five percent skimmed milk in 1X TBS-Tween 20 was
used for blocking the membrane. The membranes were
then incubated in primary antibody (1:1,000) overnight
followed by three washes with TBST each for 15 min.
Later, the membrane was incubated in HRP-conjugated
secondary antibody for 1 h and then washed thrice with
1X TBST (15 min each) and developed by using super-
signal developing reagent as HRP substrate. Primary anti-
bodies against TRAF6 (#8028; Cell Signaling Technology,
Danver, MA, USA), anti-IRAK1 (#4504; Cell SignalingTechnology), anti-IRAK2 (#4367; Cell Signaling Tech-
nology), anti-phospho-NFKB p65 (#3037; Cell Signaling
Technology), anti-NFKB p65 (#4764; Cell Signaling
Technology), anti-STAT1 (#9172 Cell Signaling Tech-
nology), anti-phospho-STAT1 (#8826 Cell Signaling
Technology), anti-JEV NS1 (#ab41651; Abcam) and
anti-β-tubulin (#ab6046; Abcam) antibodies were diluted
in 5% BSA in TBST buffer. Goat-raised HRP-conjugated
anti-rabbit secondary antibody (ab6721-1; Abcam) was
used in 1:50,000 dilution.
Luciferase assays
CHME3 cells were seeded in six-well dishes and were
transfected with NF-κB luciferase reporter plasmid
(1 μg) along with β-galactosidase (700 ng) vector by
using Lipofectamine 2000. For miR-146a overexpression
and anti-miR experiments, 100 pmol of scrambled miR
and miR-146a and 100 pmol of Cy3-labeled scrambled
anti-miR and anti-miR-146a were co-transfected along
with plasmids, and luciferase activity was measured 48 h
post transfection. For infection, cells were counted 24 h
post transfection and infected with JEV (MOI 5). Cells
were incubated for 24 h after infection and were lysed to
measure luciferase activity. ISRE and IFN-β luciferase
assay was also done in similar manner. Luciferase activ-
ity was measured 24 h post infection. For measuring the
luminescence activity, cells were lysed in 1X lysis buffer
provided by Luciferase Assay kit (#E4030; Promega,
Madison, WI, USA) and luminescence was measured by
adding luciferase assay reagent as per manufacturer’s
protocol. Luciferase activity was measured in Perkin Elmer
multiplate reader (Enspire 2300 Multimode plate reader).
The luciferase activity was normalized by β-galactosidase
activity. β-galactosidase activity was measured by using
β-Galactosidase kit (#E2000; Promega, Madison, WI, USA)
as per manufacturer’s protocol.
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CHME3 cells were seeded into six-well plate, and 100
pmol of miR-146a was transfected by using Lipofecta-
mine 2000. Scramble sequence was used as control.
Twenty four hours post transfection, JEV infection was
given, the supernatant was collected after 24 h, and
ELISA was performed to determine secreted TNF-α
level by using human TNF-α ELISA kit (#-KHC3011,
Invitrogen) according to manufacturer’s protocol. For
anti-miR experiments, 100 pmol of anti-miR-146a was
transfected along with Cy3-labeled negative control prior
to JEV infection.
Statistical analysis
All experiments were done in triplicates, and compari-
son was made between all data sets by a one-tailed, un-
paired Student’s t-test or one-way ANOVA. Data was
considered significant when P < 0.05. * denotes P < 0.05,
** denotes P < 0.005, and *** denotes P < 0.001.
Result
miR-146a gets upregulated during JEV infection
Many groups have reported increment of miR-146a
levels after viral infection [19,20]. The levels of miR-
146a were checked after JEV infection (JaOArS982
strain) (MOI 5) in CHME3 cells. TaqMan microRNA
assay was used to quantify miR-146a levels, and 1.9-fold
increase was observed in miR-146a levels, 24 h post JEV
JaOArS982 strain infection (Figure 1A). The expression
levels of miR-146a were determined at two time points
of 12 and 24 h post infection but found no change in
miR-146a levels at 12-h time point. In order to study the
strain specificity, we also checked the miR-146a levels in
cells infected by P20778, Vellore strain of JEV. As re-
ported by Pareek et al. [27], the reduced expression of
miR-146a was observed in CHME3 cells infected by
P20778, Vellore strain (Additional file 1: Figure S1A).
Thus, we conclude that endogenous miR-146a is not
relevant for replication of P20778 strain as it downregu-
lates miR-146a post viral infection. Our findings sup-
ported the strain-specific effect of JEV on the expression
of miR-146a in CHME3 cells. miR-146a is a well-known
anti-inflammatory molecule, which suppresses the release
of pro-inflammatory cytokines in activated microglial cells
[28,29]. Therefore, we checked the downstream effects of
miR-146a upregulation upon JEV infection in human
microglial cells and its effect on JEV replication.
miR-146a enhances JEV replication
Overexpression of miR-146a creates anti-inflammatory
milieu in the cell; therefore, we were interested to deter-
mine its effect on viral replication in cells. We overex-
pressed 100 pmol of miR-146a and scramble mimic and
gave JEV infection (JaOArS982 strain) after 24 h. Theviral RNA level at three time points (12, 24, and 48 h)
was checked. We found significant increase by ninefold
in viral RNA levels at 24 and a very marginal increase at
12 and 48 h post infection when compared to scramble
control (Figure 1B). The effect of miR-146a on viral rep-
lication was seen to be time point dependent and got
neutralized at 48 h after infection. To further ensure that
miR-146a enhances replication of JaOArS982 strain, we
suppressed endogenous miR-146a by transfecting anti-
miR-146a and gave JEV infection to cells. We found a
decrease in viral copy number at all three time points
(12, 24, and 48 h) but a significant dip of 75% was ob-
served at 24 h post infection (Figure 1C). Additionally,
the effect of miR-146a was checked on expression of
viral proteins. We observed the induced expression of
the JEV non-structural protein 1 (NS1) in miR-146a
overexpressing CHME3 cells as compared to scramble
transfected cells 24 h post infection (Figure 1D). Induced
expression of NS1 levels was observed at 48 h post in-
fection, which may be due to accumulation of viral pro-
teins (Figure 1D). We also determined the effect of miR-
146a on P20778 Vellore strain and found enhanced
levels of viral RNA by RT-PCR in miR-146a overexpress-
ing cells (Additional file 1: Figure S1B). These enhanced
levels of P20778 viral RNA was also due to anti-
inflammatory environment created by miR-146a overex-
pression. Hence, miR-146a creates a virus-friendly milieu
in cells, which promotes JEV replication.
JEV infection downregulates TRAF6, IRAK1, and IRAK2
genes
As JEV infection induced the expression of miR-146a in
JaOArS982 strain, therefore we focused on this strain
for our downstream studies. The levels of miR-146a tar-
get genes were checked after 24 h post JEV infection.
The downregulation in TRAF6, IRAK1, and IRAK2
levels was observed 24 h post JEV infection as compared
to uninfected cells used as control (Figure 2A). Since
these genes are major adaptor molecules involved in
NF-κB activation, the levels of phospho-p65, which is
the subunit of NF-κB activator complex, were deter-
mined by Western blotting and found a decrease in ra-
tio of phospho-p65 to total p65 post infection
(Figure 2C). NF-κB luciferase construct containing NF-
κB response element upstream firefly luciferase gene
was used to ascertain the effect of JEV infection on NF-
κB activation at various time points. β-galactosidase
vector was co-transfected in order to normalize lucifer-
ase activity with β-galactosidase activity. NF-κB lucifer-
ase assay showed an increase in the NF-κB luciferase
activity at 6 and 12 h post JEV infection, which later de-
creased at 24 h post infection. This confirmed the pres-
ence of a negative feedback loop, which suppresses the
NF-κB activity after 24 h of JEV infection as compared
Figure 1 JEV upregulates miR-146a, and miR-146a enhances viral replication. JEV infection upregulates miR-146a in CHME3 cells. (A) Human
brain microglial cell line CHME3 was infected with JEV (MOI-5), and cells were harvested at 12, 24, and 48 h post infection. qRT-PCR with Taqman
probes were used to determine miR-146a levels. RNU24 was used to normalize the fold change in miR-146a levels as compared to uninfected
control. (B,C) CHME3 cells were transfected with scramble sequence or miR-146a mimic sequence (B), Cy3-labeled scrambled anti-miR or
anti-miR-146a (C) and infected by JEV 24 h post transfection. The cells were harvested at 12, 24, and 48 h post infection for RNA isolation. Viral
RNA level was determined by RT-PCR using JEV NS3 specific primers. The fold change was normalized by GAPDH RNA levels. Fold change was
determined by 2−ΔΔCT method. For statistical analysis, scrambled miR and Cy3-labeled scrambled anti-miR group was used as control. (D) Western
blots showing upregulation of viral NS1 protein in miR-146a overexpressing cells. A 100 pmol of scrambled sequence and miR-146a mimic was
used. Scramble + JEV group was used as control for comparison. The cells were infected by JEV (MOI-5) and harvested 24 and 48 h post infection.
All the experiments were done three times independently. The data are shown as mean ± SE from three independent experiments. The fold
change is statistically significant. The fold change is significant where *denotes P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001.
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146a is suppressing NF-κB activation to create an anti-
inflammatory milieu in the cell to facilitate its survival
in host cells.miR-146a targets TRAF6, IRAK1, and IRAK2 genes
miR-146a targets genes involved in NF-κB activation. To
confirm the targeting of TRAF6, IRAK1, and IRAK2
genes by miR-146a, miR-146a mimic was overexpressed
Figure 2 (See legend on next page.)
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Figure 2 JEV downregulates TRAF6, IRAK1, IRAK2, and NF-κB activation. CHME3 cells were infected by JEV (MOI-5) and harvested 24 h post
infection. (A) Western blots showing downregulation of TRAF6, IRAK1, and IRAK2 genes. Uninfected cells were used as control. (B) Graph bars
representing densitometry plot depicting downregulation of TRAF6, IRAK1, and IRAK2 genes post JEV infection. The image density of blots was
normalized by β-tubulin by using ImageJ software. (C) Western blot showing downregulation of phospho-p65 upon JEV infection. (D) Densitometry
plot showing decreased phosphorylation of p65 subunit of NF-κB. The ratio of phospho/total p-65 decreases upon JEV infection. (E) Graph bar showing
increased NF-κB luciferase activity at 6 and 12 h after JEV infection which later decreased 24 h post JEV infection. One-way ANOVA was used to
determine statistical significance. P values were considered significant where *denotes P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001 from 6 h
sample, #P from 12 h sample. NF-κB luciferase vector was co-transfected with β-galactosidase vector. β-galactosidase activity was used to normalize
luciferase activity. All experiments were repeated thrice and are represented as mean ± SE.
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100 pmol of miR-146a and incubated for 48 h post
transfection. Additionally, CHME3 cells were also trans-
fected with scrambled miR-146a and used as a control.
Significant upregulation of miR-146a was confirmed by
TaqMan qPCR microRNA assay. TaqMan qPCR did not
show any upregulation of miR-146a in CHME3 cells
transfected with scrambled miR-146a (Figure 3C). The
Western blot analysis has shown downregulation of
TRAF6, IRAK1, and IRAK2 genes in the CHME3 cells
overexpressing miR-146a (Figure 3A).
Anti-miR-146a rescues TRAF6, IRAK1, and IRAK2 genes
during JEV infection
To further validate the role of miR-146a during JEV infec-
tion, we silenced miR-146a by using anti-miR-146a. Cy3-
labeled scramble anti-miR was used as negative control.
We confirmed the suppression of miR-146a by qPCR
(Figure 4C). By Western blot analysis, we found that anti-
miR-146a was able to rescue the expression of TRAF6,
IRAK1, and IRAK2 genes from downregulation after JEV
infection (Figure 4A). Increased expression of miR-146a
led to the downregulation of TRAF6, IRAK1, and IRAK 2
genes, and anti-miR-146a was able to neutralize the effect
of JEV on TRAF6, IRAK1, and IRAK2 genes.
miR-146a suppresses NF-κB activation and cytokine
production
To unveil the downstream effects of miR-146a overex-
pression which promoted JEV replication, the effect of
miR-146a overexpression on NF-κB activation was ana-
lyzed. The NF-κB luciferase activity was found to be
diminished by 40% in the presence of miR-146a, com-
pared to scramble control (Figure 4D). JEV infection re-
sulted into the downregulation of the luciferase activity
by 50% in presence of miR-146a. To further delineate
the suppressive effect of miR-146a, miR-146a activity
was silenced by anti-miR-146a, which led to the in-
creased luciferase activity. Elevated luciferase activity
was observed in the presence of JEV (24 h post-
infection) after anti-miR-146a transfection (Figure 4E).
JEV infection also elevated NF-κB activity in the pres-
ence of anti-miR-146a, compared to untransfected JEV-
infected cells (Figure 4E).The effect of miR-146a overexpression was checked on
cytokine production after JEV infection. JEV is known to
trigger cytokine secretion in microglial cells. To see the
effect of exogenous expression of miR-146a on JEV-
induced cytokine production, the transcript levels of
IL-6 were checked. We found reduced messenger RNA
(mRNA) levels of IL-6 in miR-146a overexpressing cells,
compared to scrambled control (Additional file 2: Figure
S2A). The levels of TNF-α was also checked by ELISA
of supernatants of JEV-infected miR-146a overexpressing
CHME3 cells, and we found reduced TNF-α secretion
(Additional file 2: Figure S2C). We also analyzed the
IFN-β promoter activity in miR-146a overexpressing
CHME3 cells after JEV infection and found 50% de-
crease in IFN-β promoter activity in the presence of
miR-146a (Additional file 2: Figure S2E).
miR-146a targets STAT1 gene
miR-146a overexpression resulted in decreased IFN-β pro-
moter activity, so the effect of miR-146a upregulation on
interferon signaling was also investigated. The expression
of STAT1 protein in miR-146a overexpressing cells was
determined. Signal transducer and activator of transcrip-
tion (STAT1) is a well-known downstream molecule in
IFN signaling which binds to Janus kinases (Jak) and trig-
gers expression of interferon-stimulated gene and is a
known to target of miR-146a. The targeting of STAT1
gene by miR-146a was confirmed in our cells, and down-
regulation in STAT1 levels was observed upon miR-146a
overexpression (Figure 5C). Anti-miR-146a rescued STAT1
from downregulation (Figure 5D).
Type I interferon activates STAT1 by its phosphoryl-
ation and dimerization. JEV has been reported to in-
crease the STAT1 phosphorylation [30]. We observed
upregulation in STAT1 phosphorylation (ser727) 12 h
post JEV infection (Figure 5A). However, the level of
total STAT1 was not changed in 12 h samples. Later,
downregulation in total and phospho-STAT1 levels
was noticed at 24 h post JEV infection (Figure 5A).
We assume that downregulation in STAT1 levels
would be due to miR-146a upregulation, which targets
expression of STAT1. To confirm our hypothesis,
miR-146a was silenced by using anti-miR-146a and
found increased STAT1 levels in the presence of JEV
Figure 3 miR-146a targets TRAF6, IRAK1, and IRAK2. CHME3
cells were transfected with 100 pmol miR-146a mimic sequence.
Scrambled seed sequence was used as control along with mock
treatment as control. The cells were harvested 48 h post transfection.
(A) Western blots showing downregulation of TRAF6, IRAK1, and
IRAK2 genes upon miR-146a overexpression. (B) Densitometry plot
showing downregulation of TRAF6, IRAK1, and IRAK2 genes upon
miR-146a overexpression. The overexpressed samples were compared
to scramble control for statistical analysis. (C) RT-PCR analysis of miR-146a
levels in miR-146a overexpressed cells. The cells were harvested 48 h
post transfection. miR-146a levels were determined by RT-PCR
by using Taqman probe. RNU24 was used for normalization. All
experiments were repeated thrice and are represented as mean ± SE.
The fold change is significant where *denotes P < 0.05, **denotes
P < 0.005, and ***denotes P < 0.001.
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lates STAT1 levels which could hinder interferon sig-
naling pathway.miR-146a suppresses JEV-induced ISRE promoter activity
Activated STAT1 dimerizes and binds to other factors to
enter the nucleus and activates the expression of
interferon-stimulated genes after binding to interferon-
stimulated response elements (ISRE) in the promoter of
interferon-inducible genes. Since miR-146a reduced the
STAT1 activation, the effect of miR-146a overexpression
was further studied on ISRE activity by ISRE luciferase
assay. miR-146a overexpressing cells displayed reduced
luciferase activity, which depicted suppression of ISRE
promoter activity upon JEV infection in miR-146a overex-
pressing cells (Figure 6A). However, we did not observe
any significant decrease in ISRE activity in scramble trans-
fected cells infected by JEV (Figure 6A). ISRE activity was
increased upon JEV infection when miR-146a was silenced
by using anti-miR-146a prior to JEV infection, compared
to Cy3-labeled, scrambled transfected cells infected by
JEV (Figure 6B).
To study the time-dependent effect of JEV infection on
ISRE activity, the luciferase activity was checked at 12 and
24 h post JEV infection. ISRE activity got increased at
early time point of 12 h of infection; but later, it decreased
at 24 h post JEV infection (Figure 6C). JEV infection sup-
pressed the ISRE activity after 24 h of JEV infection, which
weakens the cellular immune response against the virus.
Downregulation of interferon-stimulated genes by
miR-146a
STAT1 acts as a transcription factor which increases the
expression of many interferon-stimulated genes. Abroga-
tion of STAT1 gene leads to reduced ISRE activity, which
in turn affects the expression interferon-stimulated genes
(ISGs). As we observed, miR-146a downregulated STAT1
levels; therefore, the levels of ISGs were determined
after miR-146a overexpression. Interferon-induced pro-
tein with tetratricopeptide repeat (IFIT) proteins are
major interferon-induced proteins. We checked the
mRNA levels of two IFIT genes IFIT-1 and IFIT-2 after
miR-146a overexpression. About 40% reduction in IFIT-1
mRNA levels (Figure 7A) and 30% reduction in IFIT-2
levels (Figure 7C) were noticed in cells, transfected miR-
146a followed by JEV infection, compared to scramble
control mimic. Anti-miR-146a reversed the effect of
miR-146a by increasing the levels of IFIT-1 and IFIT-2
(Figure 7B,D). The miR-146a downregulates ISGs and
disrupts Jak-STAT signaling.
JEV modulates pro-inflammatory cytokines and expression
of IFIT-1 and IFIT-2
Viruses elicit the secretion of pro-inflammatory cytokines
in cells. This strategy is used by the host to restrict viral
replication and survival. JEV triggers the innate immune
response of the cells and elicits the secretion of pro-
inflammatory cytokines like IL-6 and TNF-α. Significant
Figure 4 Anti-miR-146a rescues TRAF6, IRAK1, IRAK2 genes. CHME3 cells were transfected with 100 pmol anti-miR-146a. Cy3-labeled negative
control and mock transfected cells were used as control. After 24 h of transfection, JEV infection was given (MOI 5). For better comparison, we
also used a JEV-infected group untransfected with miR-146a mimic harvested after 24 h post infection. (A) Western blots showing upregulation
of TRAF6, IRAK1, and IRAK2 genes upon silencing miR-146a. Anti-miR-146a also upregulated TRAF6, IRAK1, and IRAK2 genes after JEV infection.
(B) Densitometry plot showing upregulation of TRAF6, IRAK1, and IRAK2 genes by anti-miR-146a w.r.t. JEV infection. The image density was
normalized by β-tubulin. For statistical analysis, the protein levels of JEV-infected samples were compared to anti-miR-146a and anti-miR-146a +
JEV samples. The fold change is significant where *denotes P < 0.05, **denotes P < 0.005, ***denotes P < 0.001. (C) Taqman RT-PCR analysis of
anti-miR-146a-transfected samples to confirm silencing of miR-146a. No silencing was observed in Cy3-labeled negative control. Cy3-labeled
control was used as control for t-test. (D) Graph bars showing reduced luciferase activity upon miR-146a overexpression. JEV infection after 24 h
post miR-146a mimic transfection further reduced NF-κB activity. β-galactosidase activity was used to normalize luciferase activity. miR-146a was
overexpressed, JEV was infected, and miR-146a + JEV samples were compared to scrambled control for statistical analysis. (E) Graph showing
increased luciferase activity of NF-κB luciferase vector upon silencing of miR-146a by anti-miR-146a. Anti-miR-146a treatment 24 h prior to JEV
infection also increased NF-κB luciferase activity. JEV-infected group was used for comparison for statistical analysis. All experiments were repeated
thrice and are represented as mean ± SE. The fold change is significant where *denotes P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001.
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JEV infection at early time point of 12 h. The decrease in
levels of IL-6 and TNF-α was observed at late time point
of 24 h (Figure 8A,B). To visualize the expression of
interferon-stimulated genes after JEV infection in CHME3cells, the cells were infected and the levels of IFIT-1 and
IFIT-2 mRNA at 12 and 24 h post infection were deter-
mined. A significant increase was found in IFIT mRNA
levels 12 h post infection, which decreased later at 24 h
post infection (Figure 8C,D). So we infer that JEV
Figure 5 miR-146a upregulation by JEV targets STAT1 phosphorylation. (A) CHME3 cells were infected with JEV and pelleted at 12 and
24 h post infection. Western blots representing phospho-STAT1 and STAT1 levels at 12 and 24 h post infection. Both STAT1 and phospho-STAT1
got downregulated 24 h post infection. (B) Densitometry plot showing increase in phosphorylation of STAT1 at 12 h post infection. Later, no
increase in phosphorylation was observed 24 h after infection due to downregulation in levels of STAT1. Both phospho-STAT1 and STAT1
image density was normalized by β-tubulin. For statistical analysis, the total and phospho-STAT1 levels of 12 and 24 h JEV-infected samples
were compared to control uninfected samples at 12 and 24 h. (C) Western blot showing downregulation of STAT1 upon miR-146a mimic
overexpression. (D) Western blot showing that silencing of miR-146a by anti-miR-146a upregulates STAT1 upon JEV infection. (E) Densitometry
plot showing upregulation of STAT1 upon silencing of miR-146a. JEV infection also upregulates STAT1 when anti-miR-146a is transfected 24 h
prior to JEV infection. The image density was normalized by β-tubulin. For statistical analysis, the anti-miR-146a and anti-miR-146a + JEV groups
were compared to JEV-infected group. All experiments were repeated thrice and are represented as mean ± SE. The fold change is significant
where *denotes P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001.
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Figure 6 miR-146a suppresses ISRE promoter activity. CHME3 cells were co-transfected with 1 μg ISRE luciferase vector and 700 ng β-
galactosidase vector to measure ISRE luciferase activity. (A) Graph bars showing reduced ISRE luciferase activity upon JEV infection in miR-146a
overexpressing cells. miR-146a mimic was transfected along with vectors, and scrambled sequence was used as control for statistical analysis.
Scrambled + JEV group did not show any significant decrease in ISRE activity upon JEV infection. JEV infection was given 24 h post transfection,
and luciferase activity was measured after 24 h. (B) Graph bars showing increased ISRE luciferase activity upon JEV infection in anti-miR-146a
transfected cells. Cy3-labeled scrambled anti-miR was used as control. Anti-miR-146a increased ISRE activity upon JEV infection as compared to
scrambled Cy3 + JEV group. (C) Graph bars showing ISRE luciferase activity upon JEV infection at two time points - 12 and 24 h post infection.
The ISRE activity decreases at later time point after JEV infection. All experiments were repeated thrice and are represented as mean ± SE. The fold
change is significant where *denotes P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001.
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inflammatory cytokines at late hours of infection to sup-
press the cellular innate immune response to alleviate its
survival in the cell.Discussion
JEV infection leads to neuroinflammation in JEV-infected
patients, which leads to high morbidity and mortality.
However, the survivors still show neurological and
Figure 7 miR-146a suppresses interferon-stimulated genes. Effect of miR-146a overexpression on JEV-induced expression of interferon-stimulated
genes. The levels of IFIT-1 and IFIT-2 were determined by RT-PCR. The CT values were normalized by GAPDH levels, and fold change was calculated
by 2−ΔΔCT method. (A,C) Graph bars showing decreased expression of JEV-induced IFIT-1 (A) and IFIT-2 (C) upon miR-146a overexpression as
compared to scramble control. (B,D) Graph bars showing augmented IFIT-1 (B) and IFIT-2 (D) transcript levels upon silencing of miR-146a by
anti-miR-146a. Cy3-labeled scramble sequence was used as negative control. All experiments were repeated thrice and are represented as
mean ± SE. The fold change is significant where *denotes P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001.
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evade the innate response of host and establish pathogen-
esis [32]. Recently, Hayasaka et al. reported that JEV
JaOArS982 strain infection formed two different disease
severity groups in mice, one of which succumbed mild in-
fection with lower levels of TNF-α and IL-10 [33]. Theygot different results by using different JEV strains. They re-
ported lower titer of JaOArS982 strain in the brain of in-
fected mice, compared to the higher titer of other infective
JEV strains, which elicited lower cytokine secretion in
mice brain. This data is in support of our findings as our
results are also strain specific, and we got decreased levels
Figure 8 JEV modulates pro-inflammatory cytokine expression and expression of IFIT-1 and IFIT-2. CHME3 cells were infected by JEV,
and the effect on expression of pro-inflammatory cytokines and interferon-induced genes (IFIT-1 and IFIT-2) was determined at 12 and 24 h post
infection. (A) Graph showing the effect of JEV infection on expression of IL-6 at 12 and 24 h post infection. mRNA levels of IL-6 was determined
by RT-PCR. Decrease in IL-6 levels was demonstrated at later time point of 24 h. (B) Graph plot showing increase in TNF-α secretion 12 h post
JEV infection by ELISA. The TNF-α level was seen to be decreased after 24 h post infection. (C,D) Graph showing RT-PCR analysis of IFIT-1 (C) and
IFIT-2 (D) transcript levels at 12 and 24 h after JEV infection. Increase in IFIT-1 mRNA level was found in early 12 h of infection but later decrease
was observed (24 h). All experiments were repeated thrice and are represented as mean ± SE. The fold change is significant where *denotes
P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001.
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gests that JEV JaOArS982 strain successfully shuts down
the cellular inflammatory response to facilitate its survival.
Interferon-induced Jak-STAT pathway activates anti-viral
machinery of cells, which modulates cellular inflammatory
response [34]. Viruses are known to target STAT1 to es-
cape the IFN-induced anti-viral immune response. Simian
[35] and mumps virus [36,37] abrogate Jak-STAT signaling
by targeting STAT1. JEV has also been reported to abro-
gate the Jak-STAT pathway by blocking STAT1 phosphor-
ylation and neutralizing IFN-α-induced anti-viral response
[38]. Viruses modulate the cellular microRNA expressionfor their benefit [14]. miR-122 [39] has been reported to
facilitate HCV replication. Vesicular stomatitis, dengue,
and Chikungunya virus upregulate miR-146a to sup-
press cellular inflammatory response [19,20,21]. Entero-
virus has been reported to induce miR-141 expression
to suppress host translational machinery [40]. JEV has
been reported to upregulate miR-29b to suppress the
microglial activation [17] and miR-155 to suppress JEV-
induced inflammatory response [18]. In this study, we
deciphered the role of microRNA-146a in modulating
innate immune response and JEV pathogenesis in hu-
man microglial cells.
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miR-146a in CHME3 cells. Our results are contradictory
to findings of Pareek et al. who found downregulated
miR-146a levels upon JEV infection [27]. This discrep-
ancy may be due to different strains of virus used by
Pareek et al. To confirm this strain-specific effect of JEV,
we determined miR-146a levels in P20778 strain used by
Pareek et al. and found similar results to their findings.
This suggested that increased expression of miR-146a is
strain specific. JEV infection downregulated the adaptor
molecules TRAF6, IRAK1, and IRAK2 involved in NF-
κB activation, which are targeted by miR-146a. To de-
scribe the specific role of miR-146a in targeting of these
adaptor molecules, miR-146a was silenced and we found
that anti-miR-146a rescued TRAF6, IRAK1, and IRAK2
from downregulation upon JEV infection. To further un-
veil the downstream effects on NF-κB activity, NF-κB
promoter luciferase assay and Western blot analysis
were performed. We found reduced luciferase activity at
24 h post JEV infection and reduced phosphorylation of
NF-κB p65 subunit upon JEV infection. To confirm the
presence of negative feedback loop, we checked the NF-
κB luciferase activity at early time points (6 and 12 h)
and found initial upregulation in luciferase activity
followed by a decrease in luciferase activity at later
hours. Initial NF-κB activation by JEV preludes the miR-
146a overexpression, which further led to the downregu-
lation of adaptor proteins involved in NF-κB activation
and constitute a negative regulatory loop [41]. Hence,
we conclude that JEV-mediated upregulation of miR-
146a takes place to downregulate NF-κB activation.
miR-146a overexpression suppressed NF-κB activation
as demonstrated by luciferase assay, and inhibition of
miR-146a enhanced NF-κB activation upon JEV infec-
tion. Recently, Jin Ho Paik et al. also reported similar
results upon miR-146a overexpression [42]. Our findings
demonstrated that miR-146a creates an anti-inflammatory
environment in cells. NF-κB subunits act as transcription
factor for expression of pro-inflammatory cytokines. miR-
146a overexpression also suppressed JEV-induced cytokine
production (IL-6, TNF-α, IFN-β). The replication of JEV is
increased upon miR-146a overexpression due to an anti-
inflammatory environment created by overexpression of
miR-146a. However, this enhanced replication of viral
RNA was observed only at 24 h post infection and this ef-
fect reduced at later time points. To rule out the possibil-
ity that this reduced effect on viral replication could be
due to degradation of overexpressed miR-146a at later
hours, we checked the levels of miR-146a at later hours by
RT-PCR and found that the level of miR-146a was
retained in CHME3 cells (data not shown). We also found
elevated levels of viral NS1 protein in miR-146a overex-
pressing cells. This may be due to greater accumulation of
viral proteins in miR-146a overexpressing cells. Recently,Bing-Ching Ho et al. also reported that miR-146a sup-
ports the survival of Enterovirus in mice and silencing of
miR-146a improved the survival of Enterovirus-infected
mouse due to restoration of interferon production [43].
This suggested that the cellular anti-viral machinery got
compromised in miR-146a overexpressing cells and sup-
ported viral replication. However, a recent study by Kundu
et al. reported increased levels of SOCS1 and SOCS3 dur-
ing early time points of infection which promoted JEV
replication at early time points, but the viral titer got de-
creased due to the decrease in levels of SOCS1 and
SOCS3 during later time points, which led to the activated
cellular immune response [30]. We also found a decrease
in viral mRNA levels at later time points. This decrease
in viral titer in later time points may help the virus to
persist latently in cells. Expression of a truncated form of
viral NS1 protein and production of low virus titer in per-
sistently JEV-infected murine neuroblastoma cells as an
aftermath of virus-cell interaction [44] also depict that re-
striction of viral replication can assist viral persistence.
Decrease in viral titer at later time points may be due to
the activation of cellular immune machinery which nulli-
fied the effect of miR-146a overexpression.
miR-146a targets STAT1 gene which leads to abrogation
of Jak-STAT pathway [45]. We also found similar results,
where miR-146a overexpression reduced the STAT1 levels
and inhibition of miR-146a upregulated the STAT1 levels.
We also analyzed the effect of miR-146a overexpression
on Jak-STAT pathway. Suppression of ISRE promoter
activity and downregulated expression of interferon-
stimulated genes (ISGs) were found in miR-146a overex-
pressing cells upon JEV infection. Interferon-induced
protein with tetratricopeptide repeat (IFIT) proteins are
well-known interferon-induced anti-viral proteins, having
anti-proliferative effects [46]. IFIT-1 has been reported to
restrict JEV replication [47]. IFIT-2 has been also reported
to restrict VSV replication [48]. miR-146a downregulated
the JEV induced expression of IFIT-1 and IFIT-2. Down-
regulation of IFIT levels perturb the cellular anti-viral ma-
chinery, which helps in JEV replication in host cells. Tang
et al. has reported downregulation of other ISGs (OAS1,
Mx1, LY6E) upon miR-146a overexpression [22]. These
findings indicated that miR-146a abrogated the Jak-STAT
pathway and downregulated the expression of ISGs, which
led to the suppression of innate immune response against
the virus and augmented the viral replication in miR-146a
overexpressing cells.
We also analyzed the effect of JEV infection on STAT1
activation at different time points. JEV induced the
STAT1 activation at early time points but downregulated
the STAT1 levels at later time points due to targeting of
the STAT1 by miR-146a. Inhibition of miR-146a led to
the increased STAT1 levels upon JEV infection. The
ISRE promoter activity and expression of IFIT-1 and
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upregulation of ISRE promoter activity and levels of IFIT1
and IFIT2 upon JEV infection, which supported the activa-
tion of cellular innate immune machinery against the
virus. At 24-h time point, we found decreased levels of
IFIT1 and IFIT2 and reduced ISRE promoter activity
which indicated that the virus has successfully suppressed
the cellular inflammatory response. We observed the de-
creased expression of IL-6 and TNF-α at 24 h as com-
pared to 12 h post JEV infection. These findings suggest
that JEV-mediated miR-146a upregulation led to the sup-
pression of NF-κB activation and STAT1 degradation,
caused the downregulation of ISGs at later time point
(24 h). Downregulation of ISGs has been reported to facili-
tate persistence of virus in cells [49]. This is a strategy em-
braced by JEV to suppress the cellular inflammatory
response in human microglial cells and evade innate im-
mune response. However; this effect is time dependent
and other strategies adopted by the cell to combat viral
replication could play an important role. The host cell
triggers various anti-viral signaling pathways to curtail
viral replication. Further studies are required to find out
other anti-viral strategies adopted by JEV to evade cellular
immune response. This study demonstrated strain-specific
effects of JEV, as different JEV strains may lead to the vary-
ing downstream effects in host cellular immune responses.
Understanding the regulatory role of cellular microRNAs
during JEV infection in microglial cells would be helpful
in understanding the molecular mechanism of JEV
neuropathogenesis.Additional files
Additional file 1: Figure S1. JEV P20778 strain downregulates miR-146a
and effect of miR-146a on P20778 replication. CHME3 cells were infected by
JEV P20778 Vellore strain (MOI-5), and cells were harvested after 24 and 48 h
for RNA isolation and qPCR. (A) Graph showing downregulation in miR-146a
levels 24 and 48 h post infection obtained by RT-PCR using miR-146a-
specific Taqman probes. Uninfected control groups of the same
time points were used for comparison. RNU24 levels were used for
normalization. Fold change was determined by 2−ΔΔCT method. (B) RT-PCR
graph showing upregulated viral RNA levels in miR-146a overexpressing
cells. CHME3 cells were transfected with 100 pmol miR-146a mimic, and
P20778 JEV infection was given after 24 h. The cells were harvested 24
and 48 h post infection. Scrambled + JEV group of the same time points
was used as control for comparison. Viral RNA level was determined by
RT-PCR using JEV NS3 specific primers. The fold change was normalized
by GAPDH RNA levels. All experiments were repeated thrice and are
represented as mean ± SE. The fold change is significant where *denotes
P < 0.05, **denotes P < 0.005, and ***denotes P < 0.001.
Additional file 2: Figure S2. miR-146a suppresses cytokine expression.
Graph bars showing the effect of overexpression of miR-146a on various
cytokines upon JEV infection. miR-146a suppressed the expression of
JEV-triggered cytokines (IL-6, TNF-α, IFN-β). (A,B) RT-PCR analysis of IL-6
levels in JEV-infected miR-146a overexpressing cells. (A) miR-146a
suppressed the IL-6 expression as compared to scramble control.
Anti-miR-146a transfection increased the expression of IL-6 upon JEV
infection as compared to Cy3-labeled negative control. (B-D) Graph bars
showing ELISA of supernatants to check TNF-α secretion in miR-146aoverexpressing cells (C) and in anti-miR-146a transfected cells (D) upon
JEV infection. (E-F) Graph depicting the effect of miR-146a on IFN-β
promoter activity by IFN-β promoter luciferase assay. miR-146a suppressed
the JEV-triggered IFN-β promoter activity (E) whereas anti-miR-146a
enhanced the IFN-β promoter activity upon JEV infection (F). The
infected samples were compared to uninfected control for statistical
analysis. All experiments were repeated thrice and are represented as
mean ± SE. The fold change is significant where *denotes P < 0.05,
**denotes P < 0.005, and ***denotes P < 0.001.
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